导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -5.38% | 735/1050 |
| 近一周 | -2.81% | 890/1104 |
| 近一月 | -2.40% | 420/1103 |
| 近一季 | 3.51% | 175/1092 |
| 近半年 | -0.35% | 460/1070 |
| 近一年 | -6.83% | 699/1018 |
| 近两年 | 10.08% | 838/926 |
| 近三年 | -11.62% | 738/834 |
| 成立以来 | 89.64% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-12.36% 1034/1070 |
7.93% 573/1101 |
- - |
- - |
| 2025 | 4.18% 895/1065 |
-3.34% 966/1014 |
-1.08% 775/1038 |
10.22% 850/1050 |
-1.15% 504/1065 |
| 2024 | -0.36% 592/1011 |
0.57% 284/960 |
-3.78% 560/983 |
12.30% 435/991 |
-8.32% 838/1011 |
| 2023 | -14.27% 491/952 |
5.48% 294/880 |
-4.16% 464/895 |
-6.69% 403/915 |
-9.12% 820/952 |
| 2022 | -12.05% 118/867 |
-8.58% 79/773 |
3.10% 625/806 |
-8.82% 189/845 |
2.34% 307/867 |
| 2021 | -2.18% 382/740 |
-4.34% 316/580 |
3.78% 487/659 |
-6.01% 387/704 |
4.83% 237/740 |
| 2020 | 48.26% 244/554 |
-2.18% 220/419 |
19.38% 296/466 |
10.97% 229/517 |
14.40% 217/554 |
| 2019 | 65.10% 57/410 |
39.61% 68/1149 |
-2.97% 581/1231 |
8.70% 135/390 |
12.13% 106/410 |
| 2018 | -9.68% 7/349 |
- - |
- - |
- - |
-8.57% 184/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 万家消费成长 VS. 东吴新产业精选股票A(580008) |